Influence of natural lung surfactant inhalations on clinical symptoms and pulmonary function parameters in patients with bronchial asthma

O. Rosenberg (Saint Petersburg, Russian Federation), K. Shapovalov (Chita, Russian Federation), S. Lukyanov (Chita, Russian Federation), O. Stepanova (Chita, Russian Federation), E. Akulova (Chita, Russian Federation), A. Kochneva (Chita, Russian Federation), A. Seiliev (Saint Petersburg, Russian Federation), A. Shulga (Saint Petersburg, Russian Federation), L. Loshakova (Saint Petersburg, Russian Federation), V. Volchkov (Saint Petersburg, Russian Federation), O. Lovacheva (Moscow, Russian Federation)

Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Session: Does asthma phenotyping improve treatment?
Session type: Oral Presentation
Number: 5158
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Rosenberg (Saint Petersburg, Russian Federation), K. Shapovalov (Chita, Russian Federation), S. Lukyanov (Chita, Russian Federation), O. Stepanova (Chita, Russian Federation), E. Akulova (Chita, Russian Federation), A. Kochneva (Chita, Russian Federation), A. Seiliev (Saint Petersburg, Russian Federation), A. Shulga (Saint Petersburg, Russian Federation), L. Loshakova (Saint Petersburg, Russian Federation), V. Volchkov (Saint Petersburg, Russian Federation), O. Lovacheva (Moscow, Russian Federation). Influence of natural lung surfactant inhalations on clinical symptoms and pulmonary function parameters in patients with bronchial asthma. 5158

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of N-acetylcystein in complex basic therapy on the dynamics of pulmonary function test indices in severe bronchial asthma patients
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008

Pulmonary function changes and duration of bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 323s
Year: 2006

Influence of combined antiasthmatic basic therapy on hyperinflation in patients with severe bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 553s
Year: 2007

The lung microcirculation changes in patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 407s
Year: 2006

Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009


The bronchodilator test in patients with chronic airway obstruction: the responsiveness of lung function parameters
Source: International Congress 2018 – Respiratory physiology and measurements
Year: 2018

The glucocorticoid therapy influence on the lung microcirculation in patients with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 353s
Year: 2005

Influence of large and small dose of fluticasone propionate on clinical symptoms of bronchial asthma, lung function, bronchial hyperreactivity and eosinophilia in induced sputum
Source: Eur Respir J 2002; 20: Suppl. 38, 111s
Year: 2002

Influence of pulmonary function on spacer use for HFA-salbutamol inhalation in asthmatic patients
Source: Eur Respir J 2005; 26: Suppl. 49, 126s
Year: 2005

Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008


Pulmonary hemodynamics and respiratory function associations in children with bronchial asthma
Source: International Congress 2016 – Living with asthma around the globe
Year: 2016

Prevalence of bronchial asthma among pulmonary TB cases and impact of basic therapy of bronchial asthma on bronchial obstruction in pulmonary TB cases
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010


Therapeutic saline inhalation: effects on lung function and dyspnoea in patients with chronic obstructive airway diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 484s
Year: 2001

Influence of endogenous corticosteroids on bronchial protective properties of β2-agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010

Efficacy of long-acting bronchodilator inhalation on postoperative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Actual challenges in thoracic surgery
Year: 2008


Increased airway resistance in asthma and emphysema and its relation to other pulmonary function tests
Source: Eur Respir J 2007; 30: Suppl. 51, 618s
Year: 2007

Effect of inhaled bronchodilators on the neurovegetative status of patients with bronchial asthma
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008

Atopy, lung function and bronchial responsiveness in former paediatric asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 450s
Year: 2005

Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003



Changes in the quality of life of pulmonary TB patients depending on the severity of bronchial obstruction when using standard antituberculosis therapy and inhaled bronchodilator therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 21s
Year: 2003